|
Nov 28
|
Mydecine Announces Update Regarding the Special Access Program
|
|
Oct 18
|
Mydecine Innovations Group gearing up for human trials after completing Aquis listing
|
|
Apr 24
|
Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues
|